Status:

COMPLETED

MAGnesium Effect With ANtiosteoporotic Drugs

Lead Sponsor:

University Hospital, Clermont-Ferrand

Conditions:

Osteoporosis, Postmenopausal

Eligibility:

FEMALE

50+ years

Phase:

PHASE2

Brief Summary

Randomized pilot clinical trial to demonstrate superiority of bisphosphonate-magnesium combination over bisphosphonates alone in postmenopausal osteoporosis in slowing bone remodeling as assessed by C...

Detailed Description

A pilot, randomized, controlled, open-label, single-center, two-parallel-arm clinical trial testing the addition of oral magnesium supplementation to prescribed drug therapy in the care setting. Categ...

Eligibility Criteria

Inclusion

  • Women aged 50 years or older, with postmenopausal osteoporosis, fractured or not, requiring initiation of injectable bisphosphonate therapy as part of their care.
  • Able to give informed consent to participate in the research.
  • Affiliation to a Social Security system.

Exclusion

  • Initial densitometry more than one year old.
  • Patient receiving a treatment or food supplement containing magnesium (Mg).
  • Contra-indication to the administration of Mg: hypersensitivity to magnesium carbonate or to one of the excipients.
  • Patients with a magnesium level \> 1.07 mmol/l.
  • Patient with chronic renal failure, defined as creatinine clearance \< 35 mL/min estimated by Cockcroft-Gault or glomerular filtration rate \< 30 mL.min-1 estimated by CKD-EPI and taking into account which is more pejorative.
  • Patient with a medical and/or surgical history deemed by the investigator or his representative to be incompatible with the trial.
  • Patient under legal protection or deprived of liberty.
  • Refusal to participate.

Key Trial Info

Start Date :

June 28 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 19 2024

Estimated Enrollment :

45 Patients enrolled

Trial Details

Trial ID

NCT05328154

Start Date

June 28 2022

End Date

December 19 2024

Last Update

December 27 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

CHU clermont-ferrand

Clermont-Ferrand, France

MAGnesium Effect With ANtiosteoporotic Drugs | DecenTrialz